July 2015
Disease Control Priorities
What can structured expert judgement teach us about intervention effectiveness?Read more
September 2014
Antibiotic Resistance, Disease Control Priorities
September 2014
Antibiotic Resistance, Disease Control Priorities
September 2014
Antibiotic Resistance, Disease Control Priorities, Health and Development
August 2014
Disease Control Priorities, Health and Development
April 2014
Health and Development, Disease Control Priorities
April 2014
Disease Control Priorities, Disease Control Priorities
March 2014
Disease Control Priorities
March 2014
Disease Control Priorities
December 2013
Antibiotic Resistance, Disease Control Priorities
December 2013
Environmental Health, Disease Control Priorities
November 2013
Disease Control Priorities
This consultation continues a process begun in Seattle in October 2011. It will provide an opportunity to discuss past experience with large-scale interventions to expand RDT use, in both the public and the (formal and informal) private sectors and in urban and rural settings. Additionally...Read more
November 2013
Disease Control Priorities, Environmental Health
November 2013
Disease Control Priorities, Antibiotic Resistance
Is Methicillin-Susceptible Staphylococcus aureus (MSSA) Sequence Type 398 Confined to Northern Manhattan? Rising Prevalence of Erythromycin- and Clindamycin-Resistant MSSA Clinical Isolates in the United States.Read more
August 2011
Antibiotic Resistance, Disease Control Priorities
What is the optimum level of control of immunizing infections?Read more
September 2010
Disease Control Priorities, Antibiotic Resistance
How can financial incentives be leveraged to increase antibiotic effectiveness?Read more
August 2010
Disease Control Priorities
Vitamin A deficiency may affect 130 million children worldwideRead more
June 2010
Disease Control Priorities, Antibiotic Resistance
May 2010
Disease Control Priorities, Malaria
This week's commentary, by Dave Smith and Maciej Boni, who we are delighted to have with us at RFF, provides a brief history of attempts to control malaria. This enormously important topic is also very timely, given the development of effective new drugs to treat the disease and the current...Read more
May 2010
Antibiotic Resistance, Disease Control Priorities
In response to the challenge of sustaining the health gains achieved in the better-performing states and ensuring that the lagging states catch up with the rest of the country, the Indian government has launched the National Rural Health Mission. A central goal of the effort is to increase public...Read more
May 2010
Disease Control Priorities, Environmental Health
May 2010
Disease Control Priorities, Disease Control Priorities
This paper provides an empirical assessment of the effects of age and baseline health on willingness to pay (WTP) for mortality risk reductions by reporting the results of two contingent valuation surveys: one administered in Hamilton, Ontario and the other to a national sample of US residents...Read more
May 2010
Environmental Health, Disease Control Priorities
Using results from two contingent valuation surveys conducted in Canada and the U.S., we explore the effect of a latency period on willingness to pay (WTP) for reduced mortality risk using a structural model. We find that delaying the time at which the risk reduction occurs by 10 to 30 years...Read more
May 2010
Antibiotic Resistance, Disease Control Priorities
We interviewed commuters in Delhi, India, to estimate their willingness to pay (WTP) to reduce their risk of dying in road traffic accidents in three scenarios that mirror the circumstances under which traffic fatalities occur in Delhi. The WTP responses are internally valid: WTP increases with the...Read more
May 2010
Antibiotic Resistance, Disease Control Priorities
We consider a health authority seeking to allocate annual budgets optimally over time to minimize the discounted social cost of infection(s) evolving in a finite set of R >/= 2 groups. This optimization problem is challenging, since as is well known, the standard epidemiological model describing...Read more
May 2010
Disease Control Priorities, Disease Control Priorities
Health improvements in India, while significant, have not kept up with rapid economic growth rates. The poor in India face high out-of-pocket payments for health care, a significant burden of infectious diseases, and a rapidly increasing burden of non-communicable diseases. Against this backdrop,...Read more
May 2010
Disease Control Priorities, Disease Control Priorities
The suffering caused by neurological diseases can be prolonged, and the burden can be particularly devastating among poor populations in developing countries with inadequate or strained health care resources. Developing countries are beginning to experience high incidences of such neurological...Read more
May 2010
Disease Control Priorities, Disease Control Priorities
In their Special Communication, Dr Miller and colleagues1 stressed the need for studies that can identify whether complementary and alternative medicine (CAM) treatments produce clinically valuable placebo effects. They argued that such studies should control for the natural progression of disease...Read more
May 2010
Disease Control Priorities, Disease Control Priorities
This paper presents a simple model of preventive health care, similar to that of Grossman (1972a,b), and uses the model to define what a person would pay for a change in air quality. The model assumes that one can build up resistance to acute illness by increasing his stock of health capital; how-...Read more
May 2010
Disease Control Priorities, Disease Control Priorities
This paper presents two models of investment in health which explicitly recognize the random nature of illness and death. The first model examines life-cycle behavior of investment and health capital when the motive for investing in health is to decrease the probability of illness. In the second...Read more
